SYNOVALYTE IN PLASTIC CONTAINER pharmaceutical API fine chemical vendors

Subscribe to access the full database, or Get Started Free
Vendor	Vendor Homepage	Vendor Sku	API Url
RR Scientific	⤷ Get Started Free	R6437859	⤷ Get Started Free
>Vendor	>Vendor Homepage	>Vendor Sku	>API Url

Last updated: November 25, 2025

Introduction

Synovalyte is a medical device widely used for joint and soft tissue hydration and lubrication, often administered via intra-articular injection. While it is primarily classified as a viscous supplement containing hyaluronic acid, the production process involves sourcing high-quality Active Pharmaceutical Ingredients (APIs)—notably, hyaluronic acid (HA)—that meet stringent pharmaceutical standards. This article explores the landscape of bulk API suppliers relevant for manufacturing Synovalyte in plastic containers, highlighting sourcing strategies, regulatory considerations, and key industry players.

Understanding Synovalyte and Its API Composition

Synovalyte formulations typically comprise hyaluronic acid, a naturally occurring glycosaminoglycan providing viscoelastic properties essential for joint lubrication. The quality, molecular weight, and purity of HA critically influence the efficacy and safety profile of the final product.

Manufacturers sourcing APIs for Synovalyte must focus on APIs that are:

Pharmaceutical-grade: conforming to USP, EP, or other pharmacopeial quality standards.
Stable in formulation: maintaining activity and viscosity during storage in plastic containers.
Reliable supply chain: ensuring consistent quality and delivery times.

Major API Sources for Hyaluronic Acid (HA)

1. Natural Fermentation-Based Suppliers

Hyaluronic acid used in Synovalyte is primarily produced via microbial fermentation utilizing bacterial strains such as Streptococcus zooepidemicus. Leading suppliers leverage biotechnological processes ensuring high purity and molecular weight control.

Fidia Farmaceutici (Italy)
- Supplies pharmaceutical-grade HA derived via fermentation.
- Focuses on high molecular weight HA suitable for intra-articular injections.
- Offers APIs compliant with international pharmacopeial standards.
Allergan (AbbVie) / Lifecore
- With acquired assets from ZenPharma, they provide high-purity HA for injectable applications.
- Emphasize consistent molecular weight and batch-to-batch quality.
Contipro (Czech Republic)
- A prominent manufacturer of biotechnologically produced HA.
- Supplies bulk API for medical and cosmetic applications.
- Certified under GMP standards, suitable for pharmaceutical formulations.

2. Synthetic and Bioengineered Sources

Bioengineering advancements have led to recombinant hyaluronic acid production, offering alternatives with potentially enhanced purity and batch consistency.

Revo Biologics
- Focuses on recombinant HA using genetically modified microorganisms.
- Offers APIs with controlled molecular weight and high purity.
Fujifilm (formerly Anika Therapeutics)
- Offers bioengineered HA for injectable indications.
- Their supply chain emphasizes aseptic processing and high-quality API supply.

Regulatory and Quality Considerations

When sourcing APIs for Synovalyte, manufacturers must prioritize suppliers with:

GMP Certification: Ensures API production adheres to Good Manufacturing Practices, critical for injectable products.
Pharmacopoeial Compliance: APIs must meet USP, EP, or JP monographs to assure quality.
Traceability and Documentation: Complete batch records, Certificates of Analysis (CoA), and stability data underpin regulatory approval and product safety.

Additionally, regulatory bodies such as the FDA and EMA scrutinize the sourcing of APIs to prevent contamination, ensure bioequivalence, and maintain product integrity.

Supply Chain Strategies and Vendor Selection

Global API Suppliers: Larger providers typically possess extensive manufacturing capacities, ensuring supply stability.
Regional Suppliers: May reduce logistics costs and lead times; however, rigorous validation is necessary.

Building a diversified supplier base mitigates risks associated with single-source dependencies, such as manufacturing disruptions or quality variances.

Emerging Trends and Innovation in API Sourcing

Bioengineered Hyaluronic Acid: Companies investing in recombinant production are poised to dominate future API supplies, reducing allergen risks associated with bacterial fermentation.
Customized Molecular Weight Profiles: Suppliers now offer APIs tailored to specific viscoelastic properties, enhancing Synovalyte performance.
Sustainable Sourcing: Focus on environmentally friendly production processes aligns with industry ESG mandates.

Conclusion

Manufacturers of Synovalyte in plastic containers should prioritize high-purity, GMP-compliant hyaluronic acid from reputable suppliers. Key players include Fidia Farmaceutici, Allergan/Lifecore, Contipro, Revo Biologics, and Fujifilm. As the industry advances, bioengineered APIs with consistent quality profiles will become increasingly prevalent, offering enhanced product performance and safety.

Supplier validation, regulatory compliance, and supply chain resilience remain critical pillars for successful procurement. Engaging with established and innovative API producers ensures seamless integration into Synovalyte manufacturing workflows, optimizing patient outcomes.

Key Takeaways

Authenticity and quality of HA APIs are paramount for Synovalyte efficacy.
Reputable suppliers include Fidia, Allergan, Contipro, Revo Biologics, and Fujifilm.
Regulatory compliance (GMP, pharmacopeial standards) is essential.
Diversify supplier base to mitigate supply chain risks.
Emerging bioengineered APIs may redefine sourcing parameters.

FAQs

1. What are the main qualities to evaluate when sourcing APIs for Synovalyte?
Key qualities include purity, molecular weight, endotoxin levels, GMP certification, and compliance with pharmacopeial standards.

2. Why is recombinant hyaluronic acid gaining popularity over fermentation-derived APIs?
Recombinant HA reduces contamination risk, offers consistent molecular weights, and allows customization, improving safety and efficacy.

3. How do regulatory agencies impact API sourcing choices?
Regulatory bodies mandate strict quality controls, requiring API suppliers to hold GMP certifications, provide detailed documentation, and meet pharmacopeial standards for injectable products.

4. Can regional API suppliers be as reliable as global leaders?
Yes, provided they meet strict quality and regulatory standards. Validation of their GMP compliance and manufacturing capabilities is essential.

5. What future trends could influence API sourcing for Synovalyte?
Advances in bioengineering, personalized viscosities, and sustainability practices are poised to impact API selection and sourcing strategies.

References

[1] Fidia Farmaceutici. Hyaluronic Acid: Quality Standards & Production. [Online].
[2] Allergan/Lifecore. Hyaluronic Acid Manufacturing and Quality. [Online].
[3] Contipro. Biotech Hyaluronic Acid Production Capabilities. [Online].
[4] Revo Biologics. Recombinant Hyaluronic Acid: Innovation and Supply. [Online].
[5] Fujifilm. Bioengineered Hyaluronic Acid Use in Medical Products. [Online].

Bulk Pharmaceutical API Sources for SYNOVALYTE IN PLASTIC CONTAINER